Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: Results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR)

Jayagopal, P.B.; Sastry, Sridhar Lakshmana; Nanjappa, Veena; Abdullakutty, Jabir; Joseph, Johny; Vaidyanathan, P R; Kabra, Nitin; Manokar, P; Ghanta, Soma Sekhar; Sharma, Vinod; Mishra, Trinath Kumar; Jathappa, Narendra; Singh, Vikas; Routray, Satyanarayan; Mandal, Subroto; Bhalla, Neeraj; Dorairaj, Prabhakar; Mehta, Nihar; Kumbla, Dayanand; Rane, Abhijit Ramdas; Matia, Tapan Kumar; Jain, Dharmendra; Rege, Gautam; Modi, Sunil; Chopra, Vijay; Mohanan, P.P.; Zachariah, A Geevar; Ravindranath, Khandenahally Shankarappa; Chakraborty, Rabin; Srinivas, B.C.; Raghu, T.R.; Manjunath, Cholenahally Nanjappa

doi:10.1016/j.ijcard.2022.03.021

Cited by 13 publications

(15 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…However, in-hospital mortality has improved in the past decade in our country, possibly highlighting improved healthcare services. 9 , 10 …”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Impact of COVID-19 on heart failure hospitalization and outcome in India – A cardiological society of India study (CSI–HF in COVID 19 times study – “The COVID C–HF study”)

et al. 2023

Indian Heart Journal

Self Cite

View full text Add to dashboard Cite

“…However, in-hospital mortality has improved in the past decade in our country, possibly highlighting improved healthcare services. 9 , 10 …”

Section: Discussionmentioning

confidence: 99%

“… 5 , 6 , 7 , 8 Previous studies from our country in the non-COVID times have shown several deficiencies in acute heart failure care with sub-optimal use of guideline-directed medical therapy (GDMT) and higher mortality compared to Western countries. 9 , 10 …”

Section: Introductionmentioning

confidence: 99%

Impact of COVID-19 on heart failure hospitalization and outcome in India – A cardiological society of India study (CSI–HF in COVID 19 times study – “The COVID C–HF study”)

et al. 2023

Indian Heart Journal

Self Cite

View full text Add to dashboard Cite

“…Very low (true effect is probably markedly different from the estimated effect). 13 As indicated in these levels, the authors adjusted the level of evidence if the estimated effect may differ from the published evidence due to various factors, such as ethnicity, cultural differences and/or healthcare systems and resources, when applied in the Asia-Pacific region.…”

Section: Methodsmentioning

confidence: 99%

“…Data from the Indian College of Cardiology National Heart Failure Registry found that only 29% of HF patients had biomarker data and this limited usage was attributed to socioeconomic factors. 13 Data from other Asia-Pacific countries is lacking. Hence, in areas where NP testing is not feasible, the diagnosis would need to be supported objectively by echocardiography.…”

Section: Consensus Recommendationsmentioning

confidence: 99%

Asian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Chronic Heart Failure

Sim

Lin

Sindone

et al. 2023

J Asian Pac Soc Cardiol

View full text Add to dashboard Cite

In the Asia-Pacific region, heart failure (HF) is associated with significant health and socioeconomic burden. Given the differences in the epidemiology of HF, as well as the availability of healthcare resources between Asian and Western countries, an Asian Pacific Society of Cardiology (APSC) working group developed consensus recommendations on the management of chronic HF in the Asia-Pacific region. The APSC expert panel reviewed and appraised the available evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) system. Consensus recommendations were developed and put to an online vote. Consensus was reached when 80% of votes for a given recommendation were either ‘agree’ or ‘neutral’. The resulting statements provide guidance on the diagnosis, assessment and treatment of patients with HF with reduced, mildly reduced or preserved ejection fraction in the Asia-Pacific region.

show abstract

“…In India, of 5,269 patients with acute decompensated HF enrolled in the Indian College of Cardiology National Heart Failure Registry study, the in-hospital mortality was 6.98%, while the 30-day mortality reached 12.35%, and the 30-day rehospitalization rate was 7.98%. 54 In another study, the National Heart Failure Registry (NHFR) of India recruited 10,851 ADHF patients. Over the course of this study, a 90-day mortality rate of 14.2% was observed, alongside an 8.4% re-admission rate.…”

Section: Outcomementioning

confidence: 99%

Epidemiology and Burden of Heart Failure in Asia

Feng,

Zhang,

Zhang

2024

JACC: Asia

View full text Add to dashboard Cite

Clinical characteristics and 30-day outcomes in patients with acute decompensated heart failure: Results from Indian College of Cardiology National Heart Failure Registry (ICCNHFR)

Cited by 13 publications

References 32 publications

Impact of COVID-19 on heart failure hospitalization and outcome in India – A cardiological society of India study (CSI–HF in COVID 19 times study – “The COVID C–HF study”)

Impact of COVID-19 on heart failure hospitalization and outcome in India – A cardiological society of India study (CSI–HF in COVID 19 times study – “The COVID C–HF study”)

Asian Pacific Society of Cardiology Consensus Statements on the Diagnosis and Management of Chronic Heart Failure

Epidemiology and Burden of Heart Failure in Asia

Contact Info

Product

Resources

About